ENLV.TA
Price:
$393
Market Cap:
$29.41M
Enlivex Therapeutics Ltd. operates as a clinical-stage macrophage reprogramming immunotherapy company. It is developing Allocetra, a cell-based therapy to treat organ dysfunction and failure associated with sepsis that is in phase II clinical trial, as well as in preclinical trial to treat solid tumors. The company has a collaboration agreement with BeiGene to evaluate the safety and efficacy of Allocetra in combination with tislelizumab, an anti-PD-1 immune checkpoint inhibitor for the treatment of patients with advanced-stage solid tumors. Enlivex Therapeutics Ltd. is headquartered in Ness Ziona, Israel.
Industry
Biotechnology
IPO Date
2019-07-22
Stock Exchange
TLV
Ticker
ENLV.TA
According to Enlivex Therapeutics Ltd.’s latest financial reports and current stock price. The company's current Current Ratio is 6.43. This represents a change of -4.29% compared to the average of 6.72 of the last 4 quarters.
The mean historical Current Ratio of Enlivex Therapeutics Ltd. over the last ten years is 8.07. The current 6.43 Current Ratio has changed 7.88% with respect to the historical average. Over the past ten years (40 quarters), ENLV.TA's Current Ratio was at its highest in in the June 2021 quarter at 20.29. The Current Ratio was at its lowest in in the March 2018 quarter at 0.
Average
8.07
Median
7.90
Minimum
2.75
Maximum
18.32
Discovering the peaks and valleys of Enlivex Therapeutics Ltd. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 217.53%
Maximum Annual Current Ratio = 18.32
Minimum Annual Increase = -69.81%
Minimum Annual Current Ratio = 2.75
| Year | Current Ratio | Change |
|---|---|---|
| 2024 | 6.84 | 22.82% |
| 2023 | 5.57 | -29.67% |
| 2022 | 7.92 | -56.77% |
| 2021 | 18.32 | 110.13% |
| 2020 | 8.72 | 217.53% |
| 2019 | 2.75 | -69.81% |
| 2018 | 9.09 | 15.50% |
| 2017 | 7.87 | 44.24% |
| 2016 | 5.46 | -32.70% |
| 2015 | 8.11 | -43.76% |
The current Current Ratio of Enlivex Therapeutics Ltd. (ENLV.TA) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
6.78
5-year avg
9.47
10-year avg
8.07
Enlivex Therapeutics Ltd.’s Current Ratio is greater than Pluri Inc. (4.81), greater than Clal Biotechnology Industries Ltd. (0.11), greater than BioLineRx Ltd. (2.06), greater than Matricelf Ltd (2.69), greater than Seach Medical Group Ltd (3.34), greater than Can-Fite BioPharma Ltd. (3.60), greater than Kadimastem Ltd (0.02), greater than Nissan Medical Industries Ltd (1.01), greater than Evogene Ltd. (1.89), greater than XTL Biopharmaceuticals Ltd. (0.61),
| Company | Current Ratio | Market cap |
|---|---|---|
| 4.81 | $76.39M | |
| 0.11 | $51.76M | |
| 2.06 | $45.38M | |
| 2.69 | $90.39M | |
| 3.34 | $94.54M | |
| 3.60 | $51.22M | |
| 0.02 | $125.73M | |
| 1.01 | $91.11M | |
| 1.89 | $30.09M | |
| 0.61 | $26.44M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Enlivex Therapeutics Ltd. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Enlivex Therapeutics Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Current Ratio?
How can you use the Current Ratio?
What is Enlivex Therapeutics Ltd.'s Current Ratio?
How is the Current Ratio calculated for Enlivex Therapeutics Ltd. (ENLV.TA)?
What is the highest Current Ratio for Enlivex Therapeutics Ltd. (ENLV.TA)?
What is the 3-year average Current Ratio for Enlivex Therapeutics Ltd. (ENLV.TA)?
What is the 5-year average Current Ratio for Enlivex Therapeutics Ltd. (ENLV.TA)?
How does the current Current Ratio for Enlivex Therapeutics Ltd. (ENLV.TA) compare to its historical average?